Unjha Formulations Stock Screener | Share Price & Fundamental Analysis
UNJHAFOR
Pharmaceuticals
Screen Unjha Formulations share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹23.97
▲
0.33 (1.40%)
Market Cap
₹10.79 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.63
EPS (TTM)
₹0.91
Dividend Yield
-
Debt to Equity
-
52W High
₹29.69
52W Low
₹21.03
Operating Margin
6.00%
Profit Margin
7.14%
Revenue (TTM)
₹14.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹5.00
Total Equity
₹3.00
Unjha Formulations Share Price History - Stock Screener Chart
Screen UNJHAFOR historical share price movements with interactive charts. Analyze price trends and patterns.
Unjha Formulations Company Profile - Fundamental Screener
Screen Unjha Formulations company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for UNJHAFOR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE576D01015
Unjha Formulations Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen UNJHAFOR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 5 | 5 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Current Assets | 3 | 4 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Liabilities | ||||||||||
| Total Liabilities | 5 | 5 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | -1 | -2 | -2 | -2 | -3 | -3 | -3 | -3 | -4 | -4 |
Screen UNJHAFOR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 14 | 19 | 13 | 14 | 10 | 11 | 12 | 11 | 12 | 10 | 9 |
| Expenses | 13 | 13 | 18 | 13 | 14 | 10 | 10 | 11 | 11 | 12 | 10 | 9 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Operating Profit % | 6.00% | 4.00% | 3.00% | 3.00% | 2.00% | 1.00% | 2.00% | 3.00% | 3.00% | 3.00% | 4.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 2.30 | 0.91 | 0.62 | 0.63 | 0.56 | 0.23 | 0.69 | 0.67 | 0.59 | 0.66 | 0.57 | 0.39 |
Unjha Formulations Cash Flow Screener - Liquidity Fundamentals
Screen UNJHAFOR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
Screen UNJHAFOR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 56.80% | 56.10% | 56.19% | 58.13% | 57.78% | 56.90% | 56.61% | 59.99% |
| Other Holding | 6.28% | 6.98% | 6.88% | 4.95% | 5.30% | 6.17% | 6.47% | 2.97% |
| Shareholder Count | 4,273 | 4,213 | 4,284 | 3,933 | 3,985 | 3,969 | 4,208 | 3,993 |
Unjha Formulations Dividend Screener - Share Yield Analysis
Screen UNJHAFOR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Unjha Formulations Index Membership - Market Screener Classification
Screen UNJHAFOR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Unjha Formulations Market Events Screener - Corporate Actions
Screen UNJHAFOR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.76% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 2.42% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | -3.52% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | -1.32% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -2.81% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 12.80% |
| 2024-08-16 | 2024-08-16 | Annual General Meeting | NA | 12.61% |
Unjha Formulations Competitors Screener - Peer Comparison
Screen UNJHAFOR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,299 | 40.53 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 171,931 | 69.57 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,290 | 60.33 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,220 | 22.48 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,123 | 18.68 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,535 | 22.34 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,358 | 18.37 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,029 | 50.91 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,742 | 20.79 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,921 | 27.88 | 13,458 | 3.70% | 2,216 | 47.48 |
Unjha Formulations Company Announcements - News Screener
Screen UNJHAFOR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-12 | Publish Un-Audited Financial Results For The Quarter & Half Year Ended As On 30/09/2025 | View |
| 2025-11-10 | Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2025 And Out Come Of Board Meeting Held On 10Th November 2025 | View |
| 2025-11-10 | Board Meeting Outcome for : Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2025 And Out Come Of Board Meeting Held On 10Th November 2025 | View |
| 2025-10-29 | Board Meeting Intimation for Board Meeting - Date: 10.11.2025 (Un-Audited Financial Results For The Half Year And Quarter Ended On 30.09.2025) | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Board Meeting Outcome for Outcome Of Board Meeting - Appointment Of Company Secretary And Compliance Officer | View |
| 2025-09-05 | Submissions Of XML File For Financial Statement I.E. Balance Sheet P&L Accounts And Cash Flow Statement As On 31.03.2025 (AGM Held On 13/08/2025) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations2015 | View |
| 2025-08-13 | Filing Of Distribution Schedule | View |
| 2025-08-13 | Cash Flow Statement For The Year Ended 31.03.2025 | View |
| 2025-08-13 | Intimation Under Regulation 30 Read With Part A Of The Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations 2015 | View |
| 2025-08-13 | Regulation 44(3) Of The SEBI (Listing Obligation And Disclosure Requirements) I.E. Voting Results | View |
| 2025-08-13 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-13 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-07 | Publish Un-Audited Financial Results For The Quarter Ended As On 30/06/2025 | View |
| 2025-08-06 | Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2025 And Out Come Of Board Meeting Held On 6Th August 2025 | View |
| 2025-08-06 | Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2025 And Out Come Of Board Meeting Held On 6Th August 2025 | View |
| 2025-07-29 | E- Voting Facility At The Forthcoming Annual General Meeting & Intimation Of Fixation Of Cut-Off Date | View |
| 2025-07-21 | Board Meeting Intimation for Board Meeting - Date: 06.08.2025( Un-Audited Financial Results For The Quarter Ended On 30.06.2025) | View |
| 2025-07-18 | Regulation 47 Of SEBI(LODR) Regulations 2015.Published Notice Of AGM | View |
| 2025-07-17 | Regulation 30 & 34(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |